| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 3 | 2022 | 235 | 1.730 |
Why?
|
| Adoption | 7 | 2017 | 10 | 1.590 |
Why?
|
| Eating | 3 | 2021 | 166 | 1.400 |
Why?
|
| Parents | 6 | 2020 | 329 | 1.390 |
Why?
|
| Hawaii | 24 | 2023 | 1929 | 1.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2024 | 864 | 1.310 |
Why?
|
| Health Status | 3 | 2022 | 380 | 1.300 |
Why?
|
| Oral Health | 2 | 2020 | 68 | 1.290 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 560 | 1.240 |
Why?
|
| Humans | 77 | 2024 | 37093 | 1.220 |
Why?
|
| Students, Nursing | 3 | 2021 | 39 | 1.110 |
Why?
|
| Adult | 43 | 2024 | 11712 | 1.090 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 225 | 1.080 |
Why?
|
| Female | 57 | 2023 | 20969 | 1.040 |
Why?
|
| Health Status Disparities | 3 | 2020 | 642 | 1.040 |
Why?
|
| Male | 49 | 2024 | 20025 | 1.020 |
Why?
|
| Diabetes Mellitus | 5 | 2021 | 485 | 1.010 |
Why?
|
| Feeding Behavior | 2 | 2020 | 454 | 1.010 |
Why?
|
| Depression | 6 | 2020 | 712 | 1.000 |
Why?
|
| Quality of Life | 2 | 2020 | 481 | 0.980 |
Why?
|
| Osteoarthritis | 2 | 2021 | 20 | 0.970 |
Why?
|
| Education, Nursing, Baccalaureate | 2 | 2014 | 24 | 0.960 |
Why?
|
| Poverty | 4 | 2023 | 348 | 0.910 |
Why?
|
| Social Identification | 1 | 2023 | 58 | 0.880 |
Why?
|
| United States | 17 | 2023 | 4223 | 0.870 |
Why?
|
| Hyperkalemia | 1 | 2022 | 15 | 0.870 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 169 | 0.840 |
Why?
|
| Biomedical Research | 2 | 2023 | 400 | 0.820 |
Why?
|
| Cross-Sectional Studies | 16 | 2024 | 2721 | 0.780 |
Why?
|
| Middle Aged | 29 | 2024 | 10129 | 0.760 |
Why?
|
| Body Mass Index | 5 | 2019 | 854 | 0.760 |
Why?
|
| Child | 14 | 2022 | 3131 | 0.760 |
Why?
|
| Students | 3 | 2023 | 519 | 0.750 |
Why?
|
| Mental Health Services | 2 | 2020 | 118 | 0.740 |
Why?
|
| Aged | 22 | 2021 | 6741 | 0.740 |
Why?
|
| Medicaid | 2 | 2018 | 109 | 0.740 |
Why?
|
| Mothers | 5 | 2019 | 181 | 0.730 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2020 | 4 | 0.730 |
Why?
|
| Stroke | 2 | 2021 | 286 | 0.720 |
Why?
|
| Emotions | 2 | 2023 | 220 | 0.720 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 101 | 0.710 |
Why?
|
| Adolescent | 17 | 2021 | 5363 | 0.690 |
Why?
|
| Young Adult | 20 | 2022 | 4268 | 0.690 |
Why?
|
| Absenteeism | 1 | 2019 | 11 | 0.680 |
Why?
|
| Prevalence | 7 | 2022 | 1455 | 0.670 |
Why?
|
| Cognition | 2 | 2023 | 398 | 0.670 |
Why?
|
| Exercise | 3 | 2020 | 613 | 0.620 |
Why?
|
| Hospital Mortality | 2 | 2018 | 187 | 0.600 |
Why?
|
| Referral and Consultation | 1 | 2018 | 117 | 0.590 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2016 | 10 | 0.560 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 39 | 0.530 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2015 | 26 | 0.520 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2015 | 7 | 0.520 |
Why?
|
| Risk Adjustment | 1 | 2015 | 17 | 0.520 |
Why?
|
| Curriculum | 2 | 2014 | 265 | 0.520 |
Why?
|
| Central Nervous System | 1 | 2016 | 135 | 0.510 |
Why?
|
| Air Pollutants | 1 | 2016 | 94 | 0.510 |
Why?
|
| Nutrition Surveys | 4 | 2021 | 242 | 0.510 |
Why?
|
| Empathy | 1 | 2014 | 28 | 0.490 |
Why?
|
| Socioeconomic Factors | 9 | 2020 | 1067 | 0.480 |
Why?
|
| Internship, Nonmedical | 1 | 2014 | 2 | 0.480 |
Why?
|
| Environmental Exposure | 1 | 2016 | 216 | 0.470 |
Why?
|
| Papillomavirus Infections | 3 | 2024 | 336 | 0.460 |
Why?
|
| Depressive Disorder | 2 | 2012 | 174 | 0.450 |
Why?
|
| Leadership | 1 | 2014 | 76 | 0.450 |
Why?
|
| Hospitalization | 3 | 2022 | 388 | 0.430 |
Why?
|
| Spectrum Analysis, Raman | 4 | 2022 | 88 | 0.410 |
Why?
|
| Retrospective Studies | 10 | 2022 | 2026 | 0.400 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2010 | 23 | 0.380 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2010 | 18 | 0.380 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 2379 | 0.370 |
Why?
|
| Medicare | 4 | 2021 | 195 | 0.370 |
Why?
|
| Healthcare Disparities | 5 | 2018 | 494 | 0.360 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2009 | 7 | 0.360 |
Why?
|
| Preoperative Care | 1 | 2009 | 26 | 0.350 |
Why?
|
| Endoscopy | 1 | 2009 | 14 | 0.350 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2009 | 27 | 0.350 |
Why?
|
| Liver Transplantation | 1 | 2009 | 30 | 0.340 |
Why?
|
| Risk Factors | 7 | 2021 | 3562 | 0.340 |
Why?
|
| Biosensing Techniques | 2 | 2022 | 86 | 0.330 |
Why?
|
| Longevity | 2 | 2023 | 147 | 0.330 |
Why?
|
| Community Networks | 2 | 2020 | 108 | 0.330 |
Why?
|
| Caveolae | 1 | 2008 | 9 | 0.330 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 336 | 0.330 |
Why?
|
| Diet Surveys | 2 | 2020 | 101 | 0.320 |
Why?
|
| Anal Canal | 2 | 2019 | 30 | 0.320 |
Why?
|
| Intention | 3 | 2024 | 94 | 0.320 |
Why?
|
| Dental Care | 2 | 2020 | 26 | 0.320 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2008 | 51 | 0.320 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 935 | 0.310 |
Why?
|
| Child, Preschool | 6 | 2018 | 1418 | 0.310 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2008 | 43 | 0.310 |
Why?
|
| Physicians | 2 | 2020 | 163 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 481 | 0.300 |
Why?
|
| Mutation | 2 | 2017 | 1095 | 0.290 |
Why?
|
| Parenting | 3 | 2017 | 127 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 628 | 0.290 |
Why?
|
| Energy Intake | 3 | 2020 | 170 | 0.290 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2006 | 5 | 0.290 |
Why?
|
| Resuscitation | 2 | 2016 | 17 | 0.280 |
Why?
|
| Fathers | 2 | 2024 | 33 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2019 | 253 | 0.270 |
Why?
|
| Mass Screening | 4 | 2023 | 462 | 0.270 |
Why?
|
| Health Services Research | 2 | 2018 | 148 | 0.270 |
Why?
|
| Patient Care Team | 2 | 2016 | 47 | 0.270 |
Why?
|
| Interprofessional Relations | 2 | 2016 | 54 | 0.270 |
Why?
|
| Chickens | 1 | 2006 | 133 | 0.260 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2023 | 404 | 0.260 |
Why?
|
| Endothelial Cells | 1 | 2008 | 308 | 0.250 |
Why?
|
| Chronic Disease | 4 | 2022 | 484 | 0.250 |
Why?
|
| Sodium, Dietary | 2 | 2021 | 27 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 515 | 0.240 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2023 | 10 | 0.230 |
Why?
|
| Health | 1 | 2023 | 30 | 0.230 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 198 | 0.220 |
Why?
|
| Data Mining | 1 | 2023 | 23 | 0.220 |
Why?
|
| Civil Defense | 1 | 2023 | 11 | 0.220 |
Why?
|
| Nurses | 1 | 2023 | 48 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 16 | 0.210 |
Why?
|
| Social Isolation | 1 | 2022 | 29 | 0.210 |
Why?
|
| Databases, Factual | 1 | 2023 | 291 | 0.210 |
Why?
|
| Culture | 1 | 2023 | 173 | 0.210 |
Why?
|
| Cultural Competency | 1 | 2023 | 131 | 0.210 |
Why?
|
| Research Personnel | 1 | 2023 | 155 | 0.210 |
Why?
|
| Immunoassay | 2 | 2022 | 61 | 0.210 |
Why?
|
| Ambulatory Care | 1 | 2022 | 75 | 0.210 |
Why?
|
| Inpatients | 1 | 2022 | 74 | 0.210 |
Why?
|
| Patient Participation | 1 | 2022 | 75 | 0.200 |
Why?
|
| Mother-Child Relations | 2 | 2012 | 59 | 0.200 |
Why?
|
| Papillomavirus Vaccines | 1 | 2024 | 151 | 0.200 |
Why?
|
| Metal Nanoparticles | 2 | 2022 | 183 | 0.200 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 49 | 0.190 |
Why?
|
| Fruit | 2 | 2020 | 173 | 0.190 |
Why?
|
| Patient Readmission | 1 | 2022 | 73 | 0.190 |
Why?
|
| Genotype | 4 | 2023 | 730 | 0.190 |
Why?
|
| Family Characteristics | 2 | 2019 | 108 | 0.190 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 43 | 0.190 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2020 | 56 | 0.190 |
Why?
|
| Proteomics | 1 | 2023 | 325 | 0.190 |
Why?
|
| Health Education, Dental | 1 | 2020 | 5 | 0.180 |
Why?
|
| Nutrition Policy | 1 | 2021 | 70 | 0.180 |
Why?
|
| Diet Records | 2 | 2018 | 60 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 61 | 0.180 |
Why?
|
| Oseltamivir | 1 | 2019 | 7 | 0.180 |
Why?
|
| Body Fluids | 1 | 2019 | 17 | 0.170 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 277 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 19 | 0.170 |
Why?
|
| Signal Transduction | 1 | 2008 | 1908 | 0.170 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 19 | 0.170 |
Why?
|
| Drug Resistance, Viral | 1 | 2019 | 63 | 0.170 |
Why?
|
| Dietary Proteins | 3 | 2017 | 32 | 0.170 |
Why?
|
| Managed Care Programs | 1 | 2019 | 38 | 0.170 |
Why?
|
| Infant | 4 | 2018 | 1046 | 0.170 |
Why?
|
| Immunoconjugates | 1 | 2018 | 7 | 0.170 |
Why?
|
| Trauma Centers | 2 | 2016 | 79 | 0.170 |
Why?
|
| Clinical Competence | 2 | 2023 | 130 | 0.170 |
Why?
|
| Public Assistance | 1 | 2019 | 27 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 208 | 0.160 |
Why?
|
| Interviews as Topic | 1 | 2020 | 381 | 0.160 |
Why?
|
| Saliva | 1 | 2019 | 107 | 0.160 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 35 | 0.160 |
Why?
|
| Preventive Dentistry | 1 | 2018 | 3 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 68 | 0.160 |
Why?
|
| Antibodies | 1 | 2018 | 141 | 0.160 |
Why?
|
| Leukocytes | 1 | 2018 | 72 | 0.160 |
Why?
|
| Precancerous Conditions | 1 | 2019 | 82 | 0.160 |
Why?
|
| Oral Hygiene | 1 | 2018 | 17 | 0.160 |
Why?
|
| Health Expenditures | 1 | 2018 | 32 | 0.150 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 24 | 0.150 |
Why?
|
| Doxycycline | 1 | 2017 | 30 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2018 | 753 | 0.150 |
Why?
|
| Family | 1 | 2019 | 173 | 0.150 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 5 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 75 | 0.150 |
Why?
|
| Fee-for-Service Plans | 1 | 2017 | 17 | 0.150 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 14 | 0.150 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 10 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2017 | 18 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 113 | 0.150 |
Why?
|
| Qualitative Research | 1 | 2020 | 446 | 0.150 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 190 | 0.150 |
Why?
|
| Dental Caries | 1 | 2018 | 57 | 0.150 |
Why?
|
| Schools | 1 | 2019 | 260 | 0.150 |
Why?
|
| Communication Barriers | 1 | 2017 | 56 | 0.140 |
Why?
|
| Health Services for the Aged | 1 | 2016 | 20 | 0.140 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 110 | 0.140 |
Why?
|
| Microcephaly | 1 | 2016 | 19 | 0.140 |
Why?
|
| Stomatognathic Diseases | 1 | 2016 | 3 | 0.140 |
Why?
|
| Obstetric Labor, Premature | 1 | 2016 | 13 | 0.140 |
Why?
|
| Food Preferences | 1 | 2017 | 73 | 0.140 |
Why?
|
| Sleep Stages | 1 | 2016 | 6 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 974 | 0.140 |
Why?
|
| Nursing Staff, Hospital | 1 | 2016 | 13 | 0.140 |
Why?
|
| Primary Health Care | 1 | 2019 | 294 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 27 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 142 | 0.140 |
Why?
|
| Body Weight | 1 | 2018 | 434 | 0.140 |
Why?
|
| Vaccination | 3 | 2024 | 288 | 0.140 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 38 | 0.140 |
Why?
|
| Critical Care | 1 | 2016 | 41 | 0.140 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 55 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 90 | 0.140 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 26 | 0.140 |
Why?
|
| Pregnancy | 5 | 2022 | 1549 | 0.130 |
Why?
|
| Heterozygote | 2 | 2018 | 93 | 0.130 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 253 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2018 | 184 | 0.130 |
Why?
|
| Disease Progression | 1 | 2018 | 601 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2017 | 212 | 0.130 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 61 | 0.130 |
Why?
|
| Professional Role | 1 | 2015 | 40 | 0.130 |
Why?
|
| Diet | 2 | 2022 | 801 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2016 | 170 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2016 | 116 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 276 | 0.130 |
Why?
|
| Reference Values | 1 | 2015 | 212 | 0.130 |
Why?
|
| Asthma | 1 | 2019 | 380 | 0.120 |
Why?
|
| Confusion | 1 | 2014 | 4 | 0.120 |
Why?
|
| Arthroplasty | 1 | 2014 | 3 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 262 | 0.120 |
Why?
|
| Communication | 1 | 2016 | 180 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 21 | 0.120 |
Why?
|
| Age Factors | 2 | 2021 | 1033 | 0.120 |
Why?
|
| Nursing Evaluation Research | 1 | 2014 | 12 | 0.120 |
Why?
|
| Nursing Education Research | 1 | 2014 | 14 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 767 | 0.120 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 385 | 0.120 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 885 | 0.120 |
Why?
|
| Health Behavior | 1 | 2018 | 537 | 0.120 |
Why?
|
| Eosinophils | 1 | 2013 | 20 | 0.110 |
Why?
|
| Incidence | 2 | 2019 | 922 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 583 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2016 | 661 | 0.110 |
Why?
|
| Health Promotion | 1 | 2019 | 653 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 441 | 0.110 |
Why?
|
| Leucine | 1 | 2012 | 29 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 197 | 0.110 |
Why?
|
| Milk Proteins | 1 | 2012 | 29 | 0.110 |
Why?
|
| Comorbidity | 3 | 2020 | 623 | 0.110 |
Why?
|
| Personality | 1 | 2012 | 42 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2012 | 64 | 0.100 |
Why?
|
| Stem Cells | 1 | 2013 | 141 | 0.100 |
Why?
|
| Nitrogen | 1 | 2012 | 71 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2017 | 1378 | 0.100 |
Why?
|
| Body Composition | 1 | 2012 | 162 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 643 | 0.100 |
Why?
|
| Appetite Regulation | 1 | 2010 | 9 | 0.100 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2010 | 31 | 0.090 |
Why?
|
| Resistance Training | 1 | 2010 | 18 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 93 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 92 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2010 | 104 | 0.090 |
Why?
|
| Ligation | 1 | 2009 | 10 | 0.090 |
Why?
|
| Medical Audit | 1 | 2009 | 25 | 0.090 |
Why?
|
| Colonic Polyps | 1 | 2010 | 67 | 0.090 |
Why?
|
| Adenoma | 1 | 2010 | 89 | 0.090 |
Why?
|
| Waiting Lists | 1 | 2009 | 36 | 0.090 |
Why?
|
| Overweight | 1 | 2012 | 247 | 0.090 |
Why?
|
| Insurance Claim Review | 2 | 2020 | 28 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 448 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 190 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 898 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 1742 | 0.080 |
Why?
|
| Gold | 2 | 2022 | 136 | 0.080 |
Why?
|
| Universities | 2 | 2023 | 442 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2008 | 53 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1518 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 307 | 0.080 |
Why?
|
| Brain | 1 | 2016 | 1346 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 251 | 0.080 |
Why?
|
| Receptors, LDL | 1 | 2008 | 30 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2009 | 210 | 0.080 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2008 | 48 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 145 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2008 | 337 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 426 | 0.070 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2021 | 39 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 539 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2023 | 894 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 190 | 0.070 |
Why?
|
| Logistic Models | 2 | 2022 | 923 | 0.070 |
Why?
|
| GATA1 Transcription Factor | 1 | 2006 | 3 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2006 | 18 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 237 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2018 | 534 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2009 | 1369 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1039 | 0.060 |
Why?
|
| Binding Sites | 1 | 2006 | 651 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 286 | 0.060 |
Why?
|
| Base Sequence | 1 | 2006 | 997 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1568 | 0.060 |
Why?
|
| Emergencies | 1 | 2023 | 24 | 0.060 |
Why?
|
| Animals | 3 | 2013 | 15081 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2023 | 56 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 55 | 0.050 |
Why?
|
| Guam | 1 | 2022 | 79 | 0.050 |
Why?
|
| Cell Line | 1 | 2006 | 1354 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 938 | 0.050 |
Why?
|
| Gender Identity | 1 | 2023 | 103 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 127 | 0.050 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 40 | 0.050 |
Why?
|
| Self Care | 1 | 2023 | 159 | 0.050 |
Why?
|
| Mice | 2 | 2013 | 5913 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 204 | 0.050 |
Why?
|
| Seafood | 1 | 2021 | 23 | 0.050 |
Why?
|
| Attitude | 1 | 2021 | 104 | 0.050 |
Why?
|
| Nose | 1 | 2019 | 15 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 130 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2018 | 14 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3483 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2018 | 13 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 164 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 1492 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2017 | 9 | 0.040 |
Why?
|
| Japan | 1 | 2018 | 305 | 0.040 |
Why?
|
| Income | 1 | 2019 | 140 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 33 | 0.040 |
Why?
|
| Elastin | 1 | 2017 | 40 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 48 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 89 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2018 | 45 | 0.040 |
Why?
|
| Isoniazid | 1 | 2017 | 5 | 0.040 |
Why?
|
| Rifampin | 1 | 2017 | 4 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 321 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2020 | 322 | 0.040 |
Why?
|
| Cameroon | 1 | 2017 | 38 | 0.040 |
Why?
|
| Linear Models | 1 | 2018 | 275 | 0.040 |
Why?
|
| Philippines | 1 | 2017 | 73 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2018 | 61 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 325 | 0.040 |
Why?
|
| Garbage | 1 | 2017 | 2 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2019 | 238 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 28 | 0.040 |
Why?
|
| Child Behavior | 1 | 2017 | 78 | 0.040 |
Why?
|
| Home Care Services | 1 | 2017 | 33 | 0.040 |
Why?
|
| Blood Banks | 1 | 2016 | 10 | 0.040 |
Why?
|
| Spirituality | 1 | 2017 | 49 | 0.040 |
Why?
|
| Echocardiography | 1 | 2017 | 144 | 0.040 |
Why?
|
| Dairy Products | 1 | 2017 | 35 | 0.040 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 40 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 146 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2017 | 87 | 0.040 |
Why?
|
| Delirium | 1 | 2016 | 6 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 82 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 201 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 268 | 0.030 |
Why?
|
| Polysomnography | 1 | 2016 | 42 | 0.030 |
Why?
|
| Professional Competence | 1 | 2016 | 40 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 26 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 14 | 0.030 |
Why?
|
| Critical Illness | 1 | 2016 | 38 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 124 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2016 | 59 | 0.030 |
Why?
|
| Arousal | 1 | 2016 | 86 | 0.030 |
Why?
|
| Minority Health | 1 | 2016 | 88 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 61 | 0.030 |
Why?
|
| Video Recording | 1 | 2015 | 32 | 0.030 |
Why?
|
| Vegetables | 1 | 2017 | 147 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 562 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 208 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 739 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 465 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 448 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 400 | 0.030 |
Why?
|
| Education, Nursing, Continuing | 1 | 2014 | 12 | 0.030 |
Why?
|
| Decision Making | 1 | 2016 | 203 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2019 | 1378 | 0.030 |
Why?
|
| Esophagitis | 1 | 2013 | 6 | 0.030 |
Why?
|
| HIV-1 | 1 | 2019 | 706 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2018 | 458 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 540 | 0.030 |
Why?
|
| Appetite | 1 | 2012 | 21 | 0.030 |
Why?
|
| Personality Inventory | 1 | 2012 | 75 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 399 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 664 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 623 | 0.020 |
Why?
|
| Hunger | 1 | 2010 | 10 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 168 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 708 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 108 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 103 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2012 | 208 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2010 | 90 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 337 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1398 | 0.020 |
Why?
|